rxstat › Drug prices › Infliximab
Infliximab (Renflexis, Remsima) price in Canada
No current shortage
Infliximab 100 mg/vial powder for solution costs about $493.00 per billed unit (often a pen or vial) on public drug plan price lists across 3 provinces, before the pharmacy's dispensing fee.
Infliximab has no current shortage reported in Canada. No active reports are on file.
Price by province
| Strength and form | AB | SK | ON | NB | NS |
|---|---|---|---|---|---|
| 100 mg/vial Powder For Solution | $493.00/unit | $4.93/unit | $493.00/unit | $493.00/vial | $493.00/unit |
| 120 mg/ml Kit | $474.51/unitbrand $646.57 | $474.51/unit | $474.51/unit | $474.51/autoinjector | $474.51/unit |
| Plan coverage | Covered | Special approval | Covered | Special approval | Special approval |
What you'll pay at the pharmacy
These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.
Listed products by province
Alberta: 7 products
- Remsima Sc 120 mg/ml Kit · CHC
- Remdantry 100 mg/vial Powder For Solution · CHC
- Avsola 100 mg/vial Powder For Solution · AMG
- Ixifi 100 mg/vial Powder For Solution · PFI
- Renflexis 100 mg/vial Powder For Solution · SSB
- Remsima Sc 120 mg/ml Kit · CHC
- Remicade 100 mg/vial Powder For Solution · JAI
Saskatchewan: 6 products
- Remdantry 100 mg/vial Powder For Solution · CEL
- Renflexis 100 mg/vial Powder For Solution · ORG
- Avsola 100 mg/vial Powder For Solution · AMG
- Ixifi 100 mg/vial Powder For Solution · PFI
- Remsima Sc 120 mg/ml Kit · CEL
- Remsima Sc 120 mg/ml Kit · CEL
Ontario: 6 products
- Remsima Sc 120 mg/ml Kit · Celltrion Healthcare Co. Ltd.
- Remsima Sc 120 mg/ml Kit · Celltrion Healthcare Co. Ltd.
- Remdantry 100 mg/vial Powder For Solution · Celltrion Inc.
- Renflexis 100 mg/vial Powder For Solution · Samsung Bioepis Co. Ltd
- Ixifi 100 mg/vial Powder For Solution · Pfizer Canada Inc.
- Avsola 100 mg/vial Powder For Solution · Amgen Canada Inc.
New Brunswick: 4 products
- Remsima Sc 120 mg/ml Kit · CLT
- Renflexis 100 mg/vial Powder For Solution · ORG
- Avsola 100 mg/vial Powder For Solution · AGA
- Ixifi 100 mg/vial Powder For Solution · PFI
Nova Scotia: 7 products
- Remsima Sc 120 mg/ml Kit · CLT
- Remsima Sc 120 mg/ml Kit · CLT
- Renflexis 100 mg/vial Powder For Solution · ORG
- Avsola 100 mg/vial Powder For Solution · AGA
- Ixifi 100 mg/vial Powder For Solution · PFI
- Remicade 100 mg/vial Powder For Solution · JAN
- Remdantry 100 mg/vial Powder For Solution · HOS
Shortage status
No shortage or discontinuation reports have been filed with Health Canada for Infliximab. rxstat watches those reports through the day; sign up below to hear if that changes.
Common questions
How much does Infliximab cost in Canada?
Infliximab 100 mg/vial powder for solution costs about $493.00 per billed unit (often a pen or vial) on public drug plan price lists across 3 provinces, before the pharmacy's dispensing fee.
Is Infliximab covered by provincial drug plans?
On the public plans' own lists: Alberta: covered; Saskatchewan: special approval; Ontario: covered; New Brunswick: special approval; Nova Scotia: special approval. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Related drugs (immunosuppressants)
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.